Fennec Pharmaceuticals (FENC) Current Assets (2017 - 2025)

Fennec Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $67.0 million for Q4 2025.

• Quarterly Current Assets rose 51.94% year-over-year to $67.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.0 million (up 51.94% YoY) and the FY2025 annual result came in at $67.0 million, up 51.94% from the prior year.
• Current Assets was $67.0 million for Q4 2025 at Fennec Pharmaceuticals, up from $46.1 million in the prior quarter.
• Across five years, Current Assets topped out at $68.2 million in Q1 2024 and bottomed at $15.6 million in Q2 2022.
• A 5-year average of $35.6 million and a median of $27.9 million in 2021 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 44.6% — and 2024, when it jumped 221.62%.
• Fennec Pharmaceuticals' Current Assets stood at $22.4 million in 2021, then advanced by 19.39% to $26.7 million in 2022, then gained by 0.49% to $26.9 million in 2023, then jumped by 64.29% to $44.1 million in 2024, then surged by 51.94% to $67.0 million in 2025.
• Business Quant data shows FENC's Current Assets at $67.0 million in Q4 2025, $46.1 million in Q3 2025, and $40.8 million in Q2 2025.